Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.18 -1.26 (-2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Biomarin Pharmaceutical's Return on Capital Employed [ROCE] came in at 1.76% for Q2 2026, down 9.97 percentage points from 11.73% a year earlier and down 2.56 percentage points from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Biomarin Pharmaceutical's Return on Capital Employed [ROCE] was 6.27%, down 1.41 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +7.18 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was 7.68% in FY2024 (+4.26 pp), 3.42% in FY2023 (+0.55 pp), 2.87% in FY2022 (+4.40 pp) and -1.53% in FY2021 (-0.62 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of +0.88 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2025 (a gain of 7.21 percentage points), and the weakest in Q2 2026 (a drop of 9.97 percentage points).
  • Business Quant data shows BMRN's Return on Capital Employed [ROCE] at 4.32% (Q1 2026), 5.98% (Q4 2025) and 9.14% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Biomarin Pharmaceutical 11.07 Bn 4.93 Bn 786.91 Mn 1.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.76%
Mar 31, 2026 4.32%
Dec 31, 2025 5.98%
Sep 30, 2025 9.14%
Jun 30, 2025 11.73%
Mar 31, 2025 9.62%
Dec 31, 2024 7.67%
Sep 30, 2024 5.61%
Jun 30, 2024 4.52%
Mar 31, 2024 3.67%
Dec 31, 2023 3.30%
Sep 30, 2023 2.64%
Jun 30, 2023 1.91%
Mar 31, 2023 1.48%
Dec 31, 2022 2.81%
Sep 30, 2022 1.90%
Jun 30, 2022 1.02%
Mar 31, 2022 0.54%
Dec 31, 2021 -1.51%
Sep 30, 2021 -1.25%
API Access

Biomarin Pharmaceutical Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BMRN&period=max&api_key=YOUR_API_KEY